Voltage-Gated K + Channel Modulation by Marine Toxins: Pharmacological Innovations and Therapeutic Opportunities.

Autor: Turcio R; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Di Matteo F; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Capolupo I; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Ciaglia T; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Musella S; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Di Chio C; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (CHIBIOFARAM), University of Messina, 98166 Messina, Italy., Stagno C; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (CHIBIOFARAM), University of Messina, 98166 Messina, Italy., Campiglia P; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Bertamino A; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy., Ostacolo C; Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy.
Jazyk: angličtina
Zdroj: Marine drugs [Mar Drugs] 2024 Jul 29; Vol. 22 (8). Date of Electronic Publication: 2024 Jul 29.
DOI: 10.3390/md22080350
Abstrakt: Bioactive compounds are abundant in animals originating from marine ecosystems. Ion channels, which include sodium, potassium, calcium, and chloride, together with their numerous variants and subtypes, are the primary molecular targets of the latter. Based on their cellular targets, these venom compounds show a range of potencies and selectivity and may have some therapeutic properties. Due to their potential as medications to treat a range of (human) diseases, including pain, autoimmune disorders, and neurological diseases, marine molecules have been the focus of several studies over the last ten years. The aim of this review is on the various facets of marine (or marine-derived) molecules, ranging from structural characterization and discovery to pharmacology, culminating in the development of some "novel" candidate chemotherapeutic drugs that target potassium channels.
Databáze: MEDLINE